AAAAAA

   
Results: 1-25 | 26-39
Results: 1-25/39
Genotypic drug resistance and cause of death in HIV-infected persons who died in 1999
Authors: Beinker, NK Mayers, DL Lange, CG Valdez, H Sitkins, J Lemonnier, L Chowdhry, TK Lederman, MM
Citation: Nk. Beinker et al., Genotypic drug resistance and cause of death in HIV-infected persons who died in 1999, J ACQ IMM D, 28(3), 2001, pp. 250-253
Characterization of high-risk HIV-1 seronegative hemophiliacs
Authors: Salkowitz, JR Purvis, SF Meyerson, H Zimmerman, P O'Brien, TR Aledort, L Eyster, ME Hilgartner, M Kessler, C Konkle, BA White, GC Goedert, JJ Lederman, MM
Citation: Jr. Salkowitz et al., Characterization of high-risk HIV-1 seronegative hemophiliacs, CLIN IMMUNO, 98(2), 2001, pp. 200-211
HIV nephropathy and the Duffy antigen/receptor for chemokines in African Americans
Authors: Woolley, IJ Kalayjian, R Valdez, H Hamza, N Jacobs, G Lederman, MM Zimmerman, PA
Citation: Ij. Woolley et al., HIV nephropathy and the Duffy antigen/receptor for chemokines in African Americans, J NEPHROL, 14(5), 2001, pp. 384-387
Changing spectrum of mortality due to human immunodeficiency virus: Analysis of 260 deaths during 1995-1999
Authors: Valdez, H Chowdhry, TK Asaad, R Woolley, IJ Davis, T Davidson, R Beinker, N Gripshover, BM Salata, RA McComsey, G Weissman, SB Lederman, MM
Citation: H. Valdez et al., Changing spectrum of mortality due to human immunodeficiency virus: Analysis of 260 deaths during 1995-1999, CLIN INF D, 32(10), 2001, pp. 1487-1493
Multiple CD4(+) cell kinetic patterns and their relationships with baseline factors and virological responses in HIV type 1 patients receiving highlyactive antiretroviral therapy
Authors: Wu, HL Connick, E Kuritzkes, DR Landay, A Spritzler, J Zhang, B Spear, GT Kessler, H Lederman, MM
Citation: Hl. Wu et al., Multiple CD4(+) cell kinetic patterns and their relationships with baseline factors and virological responses in HIV type 1 patients receiving highlyactive antiretroviral therapy, AIDS RES H, 17(13), 2001, pp. 1231-1240
Effect of IL-2 therapy on plasma hepatitis C virus-RNA levels in HIV/hepatitis C virus co-infected patients
Authors: Valdez, H Metcalf, JA Gripshover, BM Jacobson, JM Mitsuyasu, R Lederman, MM
Citation: H. Valdez et al., Effect of IL-2 therapy on plasma hepatitis C virus-RNA levels in HIV/hepatitis C virus co-infected patients, AIDS, 15(5), 2001, pp. 661-662
Placebo-controlled trial of prednisone in advanced HIV-1 infection
Authors: McComsey, GA Whalen, CC Mawhorter, SD Asaad, R Valdez, H Patki, AH Klaumunzner, J Gopalakrishna, KV Calabrese, LH Lederman, MM
Citation: Ga. Mccomsey et al., Placebo-controlled trial of prednisone in advanced HIV-1 infection, AIDS, 15(3), 2001, pp. 321-327
Should physicians withhold highly active antiretroviral therapies from HIV-AIDS patients who are thought to be poorly adherent to treatment?
Authors: Sollitto, S Mehlman, M Youngner, S Lederman, MM
Citation: S. Sollitto et al., Should physicians withhold highly active antiretroviral therapies from HIV-AIDS patients who are thought to be poorly adherent to treatment?, AIDS, 15(2), 2001, pp. 153-159
Immune restoration and CD4+T-cell function with antiretroviral therapies
Authors: Lederman, MM
Citation: Mm. Lederman, Immune restoration and CD4+T-cell function with antiretroviral therapies, AIDS, 15, 2001, pp. S11-S15
Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function
Authors: Teixeira, L Valdez, H McCune, JM Koup, RA Badley, AD Hellerstein, MK Napolitano, LA Douek, DC Mbisa, G Deeks, S Harris, JM Barbour, JD Gross, BH Francis, IR Halvorsen, R Asaad, R Lederman, MM
Citation: L. Teixeira et al., Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function, AIDS, 15(14), 2001, pp. 1749-1756
Leukocyte-reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection - The viral activation transfusion study: A randomized controlled trial
Authors: Collier, AC Kalish, LA Busch, MP Gernsheimer, T Assmann, SF Lane, TA Asmuth, DM Lederman, MM Murphy, EL Kumar, P Kelley, M Flanigan, TP McMahon, DK Sacks, HS Kennedy, MS Holland, PV
Citation: Ac. Collier et al., Leukocyte-reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection - The viral activation transfusion study: A randomized controlled trial, J AM MED A, 285(12), 2001, pp. 1592-1601
Serum interleukin-6 (IL-6), IL-10, tumor necrosis factor (TNF) alpha, soluble type II TNF receptor, and transforming growth factor beta levels in human immunodeficiency virus type 1-infected individuals with Mycobacterium avium complex disease
Authors: Havlir, DV Torriani, FJ Schrier, RD Huang, JY Lederman, MM Chervenak, KA Boom, WH
Citation: Dv. Havlir et al., Serum interleukin-6 (IL-6), IL-10, tumor necrosis factor (TNF) alpha, soluble type II TNF receptor, and transforming growth factor beta levels in human immunodeficiency virus type 1-infected individuals with Mycobacterium avium complex disease, J CLIN MICR, 39(1), 2001, pp. 298-303
Differential expression of interleukin-2 and gamma interferon in human immunodeficiency virus disease
Authors: Sieg, SF Bazdar, DA Harding, CV Lederman, MM
Citation: Sf. Sieg et al., Differential expression of interleukin-2 and gamma interferon in human immunodeficiency virus disease, J VIROLOGY, 75(20), 2001, pp. 9983-9985
HIV-1 infection impairs cell cycle progression of CD4(+)T cells without affecting early activation responses
Authors: Sieg, SF Harding, CV Lederman, MM
Citation: Sf. Sieg et al., HIV-1 infection impairs cell cycle progression of CD4(+)T cells without affecting early activation responses, J CLIN INV, 108(5), 2001, pp. 757-764
Survival of transfused donor white blood cells in HIV-infected recipients
Authors: Kruskall, MS Lee, TH Assmann, SF Laycock, M Kalish, LA Lederman, MM Busch, MP
Citation: Ms. Kruskall et al., Survival of transfused donor white blood cells in HIV-infected recipients, BLOOD, 98(2), 2001, pp. 272-279
A potential role for interleukin-7 in T-cell homeostasis
Authors: Fry, TJ Connick, E Falloon, J Lederman, MM Liewehr, DJ Spritzler, J Steinberg, SM Wood, LV Yarchoan, R Zuckerman, J Landay, A Mackall, CL
Citation: Tj. Fry et al., A potential role for interleukin-7 in T-cell homeostasis, BLOOD, 97(10), 2001, pp. 2983-2990
Altered viral fitness of HIV-1 following failure of protease inhibitor-based therapy
Authors: Picchio, GR Valdez, H Sabbe, R Landay, AL Kuritzkes, DR Lederman, MM Mosier, DE
Citation: Gr. Picchio et al., Altered viral fitness of HIV-1 following failure of protease inhibitor-based therapy, J ACQ IMM D, 25(4), 2000, pp. 289-295
Preferential S phase entry and apoptosis of CD4(+) T lymphocytes of HIV-1-infected patients after in vitro cultivation
Authors: Patki, AH Zielske, SP Sieg, SF Lederman, MM
Citation: Ah. Patki et al., Preferential S phase entry and apoptosis of CD4(+) T lymphocytes of HIV-1-infected patients after in vitro cultivation, CLIN IMMUNO, 97(3), 2000, pp. 241-247
'Modeling' relationships among HIV-1 replication, immune activation and CD4+T-cell losses using adjusted correlative analyses
Authors: Lederman, MM Kalish, LA Asmuth, D Fiebig, E Mileno, M Busch, MP
Citation: Mm. Lederman et al., 'Modeling' relationships among HIV-1 replication, immune activation and CD4+T-cell losses using adjusted correlative analyses, AIDS, 14(8), 2000, pp. 951-958
Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: age inversely predicts naive CD4 cell count increase
Authors: Lederman, MM McKinnis, R Kelleher, D Cutrell, A Mellors, J Neisler, M Cooney, E Haas, DW Haubrich, R Stanford, J Horton, J Landay, A Spreen, W
Citation: Mm. Lederman et al., Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: age inversely predicts naive CD4 cell count increase, AIDS, 14(17), 2000, pp. 2635-2642
Immune responses to hepatitis C and non-hepatitis C antigens in hepatitis C virus infected and HIV-1 coinfected patients
Authors: Valdez, H Anthony, D Farukhi, F Patki, A Salkowitz, J Heeger, P Peterson, DL Post, AB Asaad, R Lederman, MM
Citation: H. Valdez et al., Immune responses to hepatitis C and non-hepatitis C antigens in hepatitis C virus infected and HIV-1 coinfected patients, AIDS, 14(15), 2000, pp. 2239-2246
Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen
Authors: Valdez, H Smith, KY Landay, A Connick, E Kuritzkes, DR Kessler, H Fox, L Spritzler, J Roe, J Lederman, MB Lederman, HM Evans, TG Heath-Chiozzi, M Lederman, MM
Citation: H. Valdez et al., Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen, AIDS, 14(1), 2000, pp. 11-21
Immune restoration with antiretroviral therapies - Implications for clinical management
Authors: Lederman, MM Valdez, H
Citation: Mm. Lederman et H. Valdez, Immune restoration with antiretroviral therapies - Implications for clinical management, J AM MED A, 284(2), 2000, pp. 223-228
Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial
Authors: Benson, CA Williams, PL Cohn, DL Becker, S Hojczyk, P Nevin, T Korvick, JA Heifets, L Child, CC Lederman, MM Reichman, RC Powderly, WG Notario, GF Wynne, BA Hafner, R
Citation: Ca. Benson et al., Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial, J INFEC DIS, 181(4), 2000, pp. 1289-1297
Effects of Mycobacterium avium complex-infection treatment on cytokine expression in human immunodeficiency virus-infected persons: Results of AIDS Clinical Trials Group Protocol 853
Authors: MacArthur, RD Lederman, MM Benson, CA Chernoff, MC MacGregor, RR Spritzler, J Mahon, LF Yen-Lieberman, B Purvis, S
Citation: Rd. Macarthur et al., Effects of Mycobacterium avium complex-infection treatment on cytokine expression in human immunodeficiency virus-infected persons: Results of AIDS Clinical Trials Group Protocol 853, J INFEC DIS, 181(4), 2000, pp. 1486-1490
Risultati: 1-25 | 26-39